Volume 21, Issue 2 pp. 184-187
Case Reports

Nonenhancing Brain Metastases

Sasan Karimi MD

Sasan Karimi MD

From the Memorial Sloan-Kettering Cancer Center, New York, NY.

Search for more papers by this author
Eric Lis MD

Eric Lis MD

From the Memorial Sloan-Kettering Cancer Center, New York, NY.

Search for more papers by this author
Saba Gilani BA

Saba Gilani BA

From the Memorial Sloan-Kettering Cancer Center, New York, NY.

Search for more papers by this author
Nicholas D'Ambrosio MD

Nicholas D'Ambrosio MD

From the Memorial Sloan-Kettering Cancer Center, New York, NY.

Search for more papers by this author
Andrei Holodny MD

Andrei Holodny MD

From the Memorial Sloan-Kettering Cancer Center, New York, NY.

Search for more papers by this author
First published: 24 March 2011
Citations: 8
Correspondence: Address correspondence to Sasan Karimi, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065. E-mail: [email protected]

J Neuroimaging 2011;21:184-187.

ABSTRACT

The hallmark radiological finding in metastatic brain disease is multiple enhancing lesions. We report a case of metastatic lung cancer to the brain with a lack of contrast enhancement. We believe that this unusual finding is due to inadvertent “treatment” of the metastases with the antiangiogenic agent bevacizumab (Avastin).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.